Wuhan Central Hospital

The trials here

What the 19 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease2 trials
• Lung cancer2 trials
• Prostate cancer2 trials
• Alzheimer disease1 trial
• Atopic dermatitis (eczema)1 trial
• Atrial fibrillation1 trial
• Colorectal cancer1 trial
• COPD1 trial
• Diabetic eye disease1 trial
• Gastric and oesophageal cancer1 trial
• Mild cognitive impairment1 trial
• Obesity1 trial
• and 5 more

Phase

• Phase 310 trials
• Phase 12 trials
• Phase 22 trials
• Phase 41 trial

Status

• Not yet recruiting7 trials
• Recruiting5 trials
• Active, not recruiting4 trials
• Completed3 trials

Lead sponsor

• Renmin Hospital of Wuhan University2 trials
• Yunhe Pharmaceutical (Tianjin) Co., Ltd2 trials
• Antengene Biologics Limited1 trial
• BeiGene1 trial
• Beijing InnoCare Pharma Tech Co., Ltd.1 trial
• and 12 more

Running trials

• Recruiting

  A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

  NCT07795346· Phase 3· Antengene Biologics Limited· Source

  Contact: Hongli Lu

• Recruiting

  Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis

  NCT07796516· Phase 2· Peking University People's Hospital· Source

  Contact: Xixi Wan

• Recruiting

  Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents

  NCT07693426· Phase 1· Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.· Source

  Contact: Weihua Wang

• Recruiting

  Low-Intensity Focused Ultrasound Targeting the Stellate Ganglion for Regulating Autonomic Nerve Function and Sleep Quality in Perioperative Patients With Cardiovascular Diseases

  NCT07595068· Renmin Hospital of Wuhan University· Source

  Contact: Long Wang, MD

• Recruiting

  Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction

  NCT07587294· Renmin Hospital of Wuhan University· Source

  Contact: Long Wang, MD

• Recruiting

  Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above

  NCT07152639· Phase 3· Chengdu CoenBiotech Co., Ltd· Source

  Contact: liu Yu

• Recruiting

  The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus

  NCT07128186· Tongji Hospital· Source

  Contact: Zhongjing Wang, Doctor

• Not yet recruiting

  A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment

  NCT06922929· Phase 3· Yunhe Pharmaceutical (Tianjin) Co., Ltd· Source

  Contact: Dong Yuan

• Not yet recruiting

  Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

  NCT06922903· Phase 3· Yunhe Pharmaceutical (Tianjin) Co., Ltd· Source

  Contact: Dong Yuan

• Active, not recruiting

  A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

  NCT06707883· Phase 2· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Source

• Recruiting

  ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis

  NCT06775860· Phase 3· Beijing InnoCare Pharma Tech Co., Ltd.· Source

  Contact: Ying Gao

• Recruiting

  Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema

  NCT07515079· Phase 3· Bio-Thera Solutions· Source

  Contact: Shuang Li

• Active, not recruiting

  Efficacy and Safety of Colchicine After PCI

  NCT06472908· Phase 3· Union Hospital, Tongji Medical College, Huazhong University of Science and Technology· Source

• Recruiting

  Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)

  NCT06157502· Phase 3· Beijing Tiantan Hospital· Source

  Contact: Ping Jing

• Active, not recruiting

  A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer

  NCT05652894· Phase 3· Taizhou Hanzhong biomedical co. LTD· Source

• Active, not recruiting

  A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)

  NCT05058040· Phase 4· Green Valley (Shanghai) Pharmaceuticals Co., Ltd.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer2 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Atrial fibrillation1 recruiting
• Coronary artery disease1 recruiting
• Diabetic eye disease1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Mild cognitive impairment1 recruiting
• Obesity1 recruiting
• Rheumatoid arthritis1 recruiting
• Stroke1 recruiting
• Tuberculosis1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  Bioequivalence Test of Hemay005 Tablets

  NCT06610903· Phase 1· Ganzhou Hemay Pharmaceutical Co., Ltd· Source

• Completed

  HTA of NIVATS Based on RWE

  NCT06574295· Fudan University· Source

• Completed

  Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

  NCT04005716· Phase 3· BeiGene· Source